"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in Harvard Catalyst Profiles by year, and whether "Aged, 80 and over" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 258 | 260 |
1995 | 1 | 326 | 327 |
1996 | 0 | 321 | 321 |
1997 | 1 | 334 | 335 |
1998 | 6 | 363 | 369 |
1999 | 2 | 416 | 418 |
2000 | 0 | 435 | 435 |
2001 | 1 | 443 | 444 |
2002 | 2 | 517 | 519 |
2003 | 1 | 583 | 584 |
2004 | 1 | 643 | 644 |
2005 | 1 | 747 | 748 |
2006 | 0 | 891 | 891 |
2007 | 0 | 914 | 914 |
2008 | 1 | 1112 | 1113 |
2009 | 0 | 1127 | 1127 |
2010 | 2 | 1230 | 1232 |
2011 | 1 | 1408 | 1409 |
2012 | 1 | 1413 | 1414 |
2013 | 1 | 1651 | 1652 |
2014 | 0 | 1665 | 1665 |
2015 | 1 | 1835 | 1836 |
2016 | 0 | 1808 | 1808 |
2017 | 1 | 1932 | 1933 |
2018 | 0 | 2105 | 2105 |
2019 | 0 | 2025 | 2025 |
2020 | 0 | 1918 | 1918 |
2021 | 0 | 1336 | 1336 |
2022 | 0 | 373 | 373 |
2023 | 0 | 281 | 281 |
2024 | 0 | 388 | 388 |
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Brain-age prediction: Systematic evaluation of site effects, and sample age range and size. Hum Brain Mapp. 2024 Jul 15; 45(10):e26768.
-
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas. Blood Adv. 2024 Jul 09; 8(13):3507-3518.
-
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood Adv. 2024 Jul 09; 8(13):3345-3359.
-
Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis. Blood Adv. 2024 Jul 09; 8(13):3427-3436.
-
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood Adv. 2024 Jul 09; 8(13):3468-3477.
-
Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial". Circulation. 2024 Jul 09; 150(2):e25-e26.
-
Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study. Neuro Oncol. 2024 Jul 05; 26(7):1292-1301.
-
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration. Alzheimers Res Ther. 2024 Jul 03; 16(1):148.
-
CSF Proteomics in Patients With Progressive Supranuclear Palsy. Neurology. 2024 Aug 13; 103(3):e209585.
-
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study. Cardiovasc Res. 2024 Jul 02; 120(8):855-868.